Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Outcomes in Chronic Myeloid Leukemia. GIMEMA QoL - CML0310.

NCT01252589 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT01252589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01252589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Outcomes in Chronic Myeloid Leukemia. GIMEMA QoL - CML0310.
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
September 30, 2013
Enrollment
480 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia